Jeff Galvin

Jeff Galvin is the CEO and founder of American Gene Technologies, a company focused on curing deadly diseases through gene therapy.

With a BA in Economics from Harvard University and over 30 years of business and entrepreneurial experience, Jeff Galvin is dedicated to innovating biotechnology solutions.

American Gene Technologies develops genetic medicines for infectious diseases, cancers, and monogenic disorders using viral vector technology.

Their programs include creating immunotherapy for HIV, activating innate Tcell immunity in immuno-oncology, treating PKU, and advancing for human proof of concept.

Gene therapy is a rapidly growing field, with enormous market potential, as indicated by industry projections.

Investors can find more information on American Gene Technologies' pipelines on their official website.